Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
RAINBOW

Rainbow Childrens Medicare Share Price

 
Stock Result Declared

 

Rainbow Childrens Medicare live price: ₹1355. It opened at ₹1,358 vs previous close ₹1,345; intraday high/low: ₹1,360/₹1,322. The 50 & 200 DMA stand at ₹1,264.47/₹1,295.55.

Rainbow Childrens Medicare Performance

  • Today's Low
  • ₹1,322
  • Today's High
  • ₹1,360
  • 52 Week Low
  • ₹1,084
  • 52 Week High
  • ₹1,646
  • Open Price₹1,358
  • Previous Close₹1,345
  • Volume121,726
  • 50 DMA₹1,264.47
  • 100 DMA₹1,261.94
  • 200 DMA₹1,295.55

Rainbow Childrens Medicare Chart

Investment Returns

  • Over 1 Month + 4.73%
  • Over 3 Month + 13.2%
  • Over 6 Month + 1.88%
  • Over 1 Year 0.01%

Smart Investing Starts Here Start SIP with Rainbow Childrens Medicare for Steady Growth!

Invest Now

Rainbow Childrens Medicare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 49.4
  • PEG Ratio
  • 3.4
  • Market Cap Cr
  • 13,761
  • P/B Ratio
  • 8.6
  • Average True Range
  • 37.84
  • EPS
  • 25.37
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 27.3
  • RSI
  • 66.76
  • MFI
  • 74.29

Latest Stock News Updates

Rainbow Childrens Medicare Ltd. Results Earnings Call for Q3FY26

Conference Call with Rainbow Childrens Medicare Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.

Q3FY26 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Healthcare Facilities company Rainbow Childrens Medicare announced Q3FY26 results Revenue: Rs 4,454.48 million against Rs 3,980.82 million during Q3FY25, change 12%. PBT: Rs 976.94 million against Rs 943.27 million during Q3FY25, change 4%. PAT: Rs 738.97 million against Rs 689.41 million during Q3FY25, change 7%. EPS: 7.14 for Q3FY26. Ramesh Kancharla, Chairman & Managing Director, Rainbow Children’s Medicare, said: “Over the last year, we have invested meaningfully in expanding our presence and strengthening our clinical capabilities. As we near the completion of this phase, our focus is shifting toward performance, consistency, and clinic outcomes across all markets. Our new hospitals in Guwahati, Warangal, and Rajahmundry have integrated well into the Rainbow network, with their ramp-up progressing broadly in line with expectations. In Bengaluru, the recently commissioned Electronic City hospital and the upcoming Hennur hospital will further deepen our presence and improve access across key micro-markets in Bengaluru. Mr. Abrarali Dalal joining as Chief Executive Officer aligns well with the organization transitioning from expansion led growth to execution excellence, scalability and consistency across group hospitals.” Result PDF

We will infuse 1,000 crore over the next 3 years: Rainbow Children's Medicare CMD Ramesh Kancharla

Rainbow Childrens Medicare Financials

Rainbow Childrens Medicare Technicals

EMA & SMA

Current Price
₹1,355.00
+ 10.2 (0.76%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,304.63
  • 50 Day
  • ₹1,264.47
  • 100 Day
  • ₹1,261.94
  • 200 Day
  • ₹1,295.55

Resistance and Support

1345.67 Pivot Speed
  • R3 1,407.33
  • R2 1,383.67
  • R1 1,369.33
  • S1 1,331.33
  • S2 1,307.67
  • S3 1,293.33

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Rainbow Children’s Medicare Ltd. is a leading pediatric healthcare provider in India, offering specialized medical services for children, including neonatal, pediatric, and maternity care. It operates a network of hospitals dedicated to child and maternal health.

Rainbow Children's Medicare has an operating revenue of Rs. 1,613.28 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 22% is great, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 9% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Rainbow Childrens Medicare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-23 Audited Results, Final Dividend & A.G.M.
2026-01-28 Quarterly Results
2025-11-13 Quarterly Results
2025-07-26 Quarterly Results
2025-05-24 Audited Results, Final Dividend & A.G.M.
Date Purpose Remarks
2025-06-28 FINAL Rs.3.00 per share(30%)Final Dividend
2024-07-23 FINAL Rs.3.00 per share(30%)Final Dividend
2023-06-22 FINAL Rs.3.00 per share(30%)Final Dividend
2022-09-08 FINAL Rs.2.00 per share(20%)Final Dividend
View Rainbow Childrens Medicare Dividend History Arrow

Rainbow Childrens Medicare Shareholding Pattern

49.84%
17.46%
1.97%
17.24%
10.7%
2.79%

Rainbow Childrens Medicare FAQs

Rainbow Childrens Medicare share price is ₹1,355 As on 24 May, 2026 | 03:19

The Market Cap of Rainbow Childrens Medicare is ₹13761.3 Cr As on 24 May, 2026 | 03:19

The P/E ratio of Rainbow Childrens Medicare is 49.4 As on 24 May, 2026 | 03:19

The PB ratio of Rainbow Childrens Medicare is 8.6 As on 24 May, 2026 | 03:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23